
Risks and Responses: Our Portfolio Positioning for 2025 - bbh.com
2025年2月7日 · 2 Beta is a measure of a portfolio’s sensitivity to market movements. The beta of the broader equity market, as measured by the S&P 500, is 1.00 (Source: Morningstar). 3 …
Should You Invest in the VanEck Biotech ETF (BBH)?
2025年2月25日 · The ETF has a beta of 0.72 and standard deviation of 20.39% for the trailing three-year period, making it a high risk choice in the space. With about 27 holdings, it has …
BBH’s 10th Annual Global ETF Investor Survey captures the opinions of ETF-focused investors around the world about how they are selecting and utilizing ETFs in their portfolios. This year …
VanEck Biotech ETF ETF Price, Holdings, & News (NASDAQ:BBH)
5 天之前 · Should You Buy or Sell VanEck Biotech ETF Stock? Get The Latest BBH Stock Price, Constituents List, Holdings Data, Headlines, and Short Interest at MarketBeat.
BBH vs. IBB — ETF Comparison Tool - PortfoliosLab
4 天之前 · Compare BBH and IBB across key investment metrics, including historical performance, risk, expense ratio, dividends, Sharpe ratio, and more, to determine which asset …
大模型BBH评测基准详情以及最新排行结果 | 数据学习 (DataLearner)
查看BBH介绍、评测指标、官方数据集链接、详细测试结果及大模型排名,掌握 AI 评测趋势!
BBH vs. HELX — ETF Comparison Tool - PortfoliosLab
4 天之前 · This table presents a comparison of risk-adjusted performance metrics for VanEck Vectors Biotech ETF (BBH) and Franklin Genomic Advancements ETF (HELX). Risk-adjusted …
Independent Advisor Alliance Makes New $250,000 ... - ETF Daily …
2 天之前 · Read Independent Advisor Alliance Makes New $250,000 Investment in VanEck Biotech ETF (NASDAQ:BBH) at ETF Daily News. ... a price-to-earnings ratio of 33.67 and a …
2024 Global ETF Investor Survey - Brown Brothers Harriman
2024年5月21日 · BBH’s 11th Annual Global ETF Investor Survey unlocks the trends, strategies, and product innovations driving the next evolution in ETFs, including a special section: The …
Capital Partners, Investor Services - Brown Brothers Harriman
Provides advice, capital, and differentiated investment strategies to business owners, high-net-worth individuals, families, foundations, endowments, and institutional investors. Provides …